4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000020
Chief Medical Officer sold 7,000 shares at an average $32.37 ($226,559)
- Chief Medical Officer acquired 7,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goncalves Joana · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,500 | $6.84 | $23,940 | 37,518 | D |
| 2026-02-17 | Exercise or conversion : show line 2 in the form 10b5-1 | +3,500 | $7.80 | $27,300 | 41,018 | D |
| 2026-02-17 | Sale : show line 3 in the form 10b5-1 | −6,064 | $32.30 | $195,873 | 34,954 | D |
| 2026-02-17 | Sale : show line 4 in the form 10b5-1 | −936 | $32.78 | $30,686 | 34,018 | D |
| Open-market sales · 7,000 sh · avg $32.37 · $226,559 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-17 | Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) | −3,500 | 218,063 | D |
| 2026-02-17 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Warrant (right to buy) | −3,500 | 189,492 | D |
Loading xslF345X05/form4.xml…